Revlimid (lenalidomide)

pCPA File Number: 20840

Negotiation Status:

Concluded with an LOI

Indication(s):

Multiple Myeloma (newly diagnosed)

Sponsor/Manufacturer:

Celgene Inc.

CDA-AMC Project Number:

PC0061-000

pCPA Engagement Letter Issued:

2015-12-10

Negotiation Process Concluded:

2016-09-14